Insights on the Pediatric Drugs and Vaccines Global Market to 2027 - Featuring Abbott Laboratories, Allergan and Amgen Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Pediatric Drugs and Vaccines - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Pediatric Drugs and Vaccines estimated at US$100.1 Billion in the year 2020, is projected to reach a revised size of US$148.8 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027.

Antibiotics, one of the segments analyzed in the report, is projected to record a 5.9% CAGR and reach US$36.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Vaccines segment is readjusted to a revised 6.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $27.1 Billion, While China is Forecast to Grow at 8.9% CAGR

The Pediatric Drugs and Vaccines market in the U.S. is estimated at US$27.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$31.4 Billion by the year 2027 trailing a CAGR of 8.9% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Allergy & Respiratory Segment to Record 4.3% CAGR

In the global Allergy & Respiratory segment, USA, Canada, Japan, China and Europe will drive the 3.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$14.1 Billion in the year 2020 will reach a projected size of US$18.4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$20.1 Billion by the year 2027, while Latin America will expand at a 5.3% CAGR through the analysis period.

Select Competitors (Total 90 Featured):

• Abbott Laboratories
• Allergan Inc.
• Amgen Inc.
• AstraZeneca Plc
• Boehringer Ingelheim GmbH
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• Genentech Inc.
• GlaxoSmithKline Plc
• Janssen Biologics B.V
• Merck & Co. Inc.
• Novartis AG
• Novo Nordisk A/S
• Pfizer Inc.
• Sanofi
• Shionogi Inc.
• Shire Pharmaceuticals Group Plc

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Pediatrics: A Highly Underserved and Undervalued Group
• Recent Market Activity
• Pediatric Drugs Market - An Abode of Opportunities
• The United States: Largest Market for Pediatric Drugs and Vaccines
• Developing Markets to Witness Faster Growth
• Antibiotics: Largest Selling Drug Classes
• Pediatric Vaccines Market - On High Growth Trajectory
• Supply and Demand Dynamics of the Global Vaccine Market
• UNICEF Addresses BCG Vaccine Supply Shortage
• Access to Vaccines Index: Aiding Increased Access to Vaccines
• Recent Advancements/Achievements in the Pediatric Vaccines Space
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

• Pediatric Exclusivity Drives Manufacturers' Interest
• Pediatric Exclusivity Granted to Branded Drugs
• New Product Approvals and Pipeline - A Key Growth Propeller
• Recent Pediatric Drug Approvals: 2015-2017
• Pediatric Drug Approvals: 2011-2014
• Phase III Completed Pediatric Drugs: 2015-2017 (As of July 2017)
• Ongoing Phase III Pediatric Drugs Clinical Trials: 2015-2017 (As of July 2017)
• Potential for Pediatric Drugs Against Obesity-related Conditions
• List of Pediatric Drugs for Congestive Heart Failure Treatment
• Recent Findings to Help Save Children's Lives
• Challenges of Pediatric Drug Development: Formulation Problems and Ethical Constraints of Clinical Trials
• Financial Enticement for Drug Makers to Conduct Dedicated Pediatric Trials
• Modeling & Simulation - A Powerful Tool for Pediatric Clinical Study Sponsors
• Pharmacometrics Approaches Gain Traction Among US and EU Researchers
• Challenges Associated with Adoption of Pharmacometric Approach
• Guidelines for Conducting Ethically Correct Clinical Trials
• Pediatric Drug Market - Is Off-label Prescription Justified?
• Indian Drug Manufacturers Develop Pneumococcal Conjugate Vaccine
• High Vaccination Costs: A Major Hindrance for Pneumonia Vaccination
• Vaccine Refusal by Parents - A Growing Trend in the US Market
• Orphan Drugs for Pediatric Use Gain Popularity
• List of FDA Approved Orphan Drugs: 2015-2016
• List of FDA Designated Orphan Drugs: 2015-2017
• Pediatric Review Vouchers Foster Innovation in Rare Pediatric Drugs
• Need for Higher Focus on Fixed-Dose Combination for Pediatric HIV Infections
• Approved Pediatric Antiretroviral Drugs for HIV Treatment
• Highly Fragmented Growth Hormone Market

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/tballr